Royalty Pharma
RPRX
#772
Rank
S$43.33 B
Marketcap
S$75.00
Share price
-1.11%
Change (1 day)
61.72%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: S$43.33 Billion

As of August 2026 Royalty Pharma has a market cap of S$43.33 Billion. This makes Royalty Pharma the world's 772th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026S$43.33 B47.58%
2025S$29.36 B43.57%
2024S$20.45 B-8.05%
2023S$22.24 B-4.82%
2022S$23.36 B1%
2021S$23.13 B-9.96%
2020S$25.69 B

End of Day market cap according to different sources

On Aug 12th, 2026 the market cap of Royalty Pharma was reported to be:

S$43.61 Billion
by Nasdaq info icon info icon
S$43.82 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
S$248.21 B 472.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.380 T 3,084.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
S$2.19 B-94.92%๐Ÿ‡บ๐Ÿ‡ธ USA